These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7858398)

  • 21. Diffuse cutaneous leishmaniasis in Mexico.
    Velasco O; Savarino SJ; Walton BC; Gam AA; Neva FA
    Am J Trop Med Hyg; 1989 Sep; 41(3):280-8. PubMed ID: 2802018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase of NK cells and proinflammatory monocytes are associated with the clinical improvement of diffuse cutaneous leishmaniasis after immunochemotherapy with BCG/Leishmania antigens.
    Pereira LI; Dorta ML; Pereira AJ; Bastos RP; Oliveira MA; Pinto SA; Galdino H; Mayrink W; Barcelos W; Toledo VP; Lima GM; Ribeiro-Dias F
    Am J Trop Med Hyg; 2009 Sep; 81(3):378-83. PubMed ID: 19706899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental treatment of cutaneous leishmaniasis with argentilactone isolated from Annona haematantha.
    Waechter AI; Ferreira ME; Fournet A; Rojas de Arias A; Nakayama H; Torres S; Hocquemiller R; Cavé A
    Planta Med; 1997 Oct; 63(5):433-5. PubMed ID: 9342948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of cutaneous lesions caused by Leishmania mexicana in plasminogen-deficient mice.
    Maldonado J; Marina C; Puig J; Maizo Z; Avilan L
    Exp Mol Pathol; 2006 Jun; 80(3):289-94. PubMed ID: 16081064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leishmania mexicana H-line attenuated under pressure of gentamicin, potentiates a Th1 response and control of cutaneous leishmaniasis in BALB/c mice.
    Daneshvar H; Hagan P; Phillips RS
    Parasite Immunol; 2003; 25(11-12):589-96. PubMed ID: 15053780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment.
    Calvopina M; Gomez EA; Sindermann H; Cooper PJ; Hashiguchi Y
    Am J Trop Med Hyg; 2006 Dec; 75(6):1074-7. PubMed ID: 17172368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis.
    Stamm LM; Räisänen-Sokolowski A; Okano M; Russell ME; David JR; Satoskar AR
    J Immunol; 1998 Dec; 161(11):6180-8. PubMed ID: 9834104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Two Different Isolates of
    Rivera-Fernández I; Argueta-Donohué J; Wilkins-Rodríguez AA; Gutiérrez-Kobeh L
    J Parasitol; 2019 Apr; 105(2):359-370. PubMed ID: 31033389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo and in vitro control of Leishmania mexicana due to garlic-induced NO production.
    Gamboa-León MR; Aranda-González I; Mut-Martín M; García-Miss MR; Dumonteil E
    Scand J Immunol; 2007 Nov; 66(5):508-14. PubMed ID: 17953527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Histological observation on cutaneous leishmaniasis produced by 2 species of Leishmania].
    Yang YQ; Yang HZ; Guan LR
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1987; 5(2):121-3. PubMed ID: 3652411
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
    Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
    Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study of DNA vaccines encoding various antigens against Leishmania mexicana.
    Dumonteil E; Andrade-Narvarez F; Escobedo-Ortegon J; Ramirez-Sierra MJ; Valencia-Pacheco G; Flores-Serrano A; Canto-Lara S; Arjona-Torres A
    Dev Biol (Basel); 2000; 104():135-41. PubMed ID: 11713811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
    Iborra S; Carrión J; Anderson C; Alonso C; Sacks D; Soto M
    Infect Immun; 2005 Sep; 73(9):5842-52. PubMed ID: 16113303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance of mice to experimental leishmaniasis is associated with more rapid appearance of mature macrophages in vitro and in vivo.
    Sunderkötter C; Kunz M; Steinbrink K; Meinardus-Hager G; Goebeler M; Bildau H; Sorg C
    J Immunol; 1993 Nov; 151(9):4891-901. PubMed ID: 8409447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leishmania major: differential resistance to infection in C57BL/6 (high interferon-alpha/beta) and congenic B6.C-H-28c (low interferon-alpha/beta) mice.
    Shankar AH; Morin P; Titus RG
    Exp Parasitol; 1996 Nov; 84(2):136-43. PubMed ID: 8932763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GK1 Improves the Immune Response Induced by Dendritic Cells of BALB/c Mice Infected with Leishmania mexicana Promastigotes.
    Gutiérrez-Kobeh L; Wilkins-Rodríguez AA
    Acta Parasitol; 2020 Mar; 65(1):27-35. PubMed ID: 31571138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cutaneous leishmaniasis caused by Leishmania mexicana in Durango, Mexico: first clinical case report].
    Pérez-Vega JH; López-Moreno CY; López-Valenzuela JA; Rendón-Maldonado JG; López-Moreno HS
    Gac Med Mex; 2009; 145(5):433-5. PubMed ID: 20073449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An essential role for IL-13 in maintaining a non-healing response following Leishmania mexicana infection.
    Alexander J; Brombacher F; McGachy HA; McKenzie AN; Walker W; Carter KC
    Eur J Immunol; 2002 Oct; 32(10):2923-33. PubMed ID: 12355446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SCID mice reconstituted with IL-4-deficient lymphocytes, but not immunocompetent lymphocytes, are resistant to cutaneous leishmaniasis.
    Satoskar A; Brombacher F; Dai WJ; McInnes I; Liew FY; Alexander J; Walker W
    J Immunol; 1997 Nov; 159(10):5005-13. PubMed ID: 9366428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular experimental leishmaniasis in C57BL/10 and BALB/c mice induced by Leishmania amazonensis infection.
    Calabrese KS; Silva LS; Hardoim DJ; Souza CS; Abreu-Silva AL
    Exp Parasitol; 2013 Feb; 133(2):156-61. PubMed ID: 23201219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.